Construction of Tumor-specific Oncolytic Adenovirus Vector and its Primary Study on Selective Expression in Tumor Cells

Pu Yingyan,Fang Lin,Shen Quan,Sun Lijun,Hu Xiaocui,Wang Yan,Cao Xiangrong,Su Changqing

DOI: https://doi.org/10.3969/j.issn.1001-4616.2008.02.019

2008-01-01

Abstract:To develop a novel gene therapeutic oncolytic adenovirus in which the hTERT promoter was introduced and used to regulate adenoviral E1A gene.A novel cancer-specific replication-competent adenovirus named AdSU was constructed by employing the human telomerase reverse transcriptase(hTERT)promoter to drive the expression of adenovirus E1A gene and by cloning the EGFP reporter gene into the adenovirus genome.The non-replicative adenovirus named Ad-EGFP was constructed as the control at the same time.The selective replication of AdSU-EGFP in tumor cells was investigated by virus proliferative test and Western blot assay.By western blot assay,E1A protein was positive in cancer cells(MHCC,A549)infected with AdSU-EGFP,but negative in normal cells(BJ,uterine fibroblast).Under the fluorescent microscope,a few normal cells expressed EGFP and emitted fluorescence,and no phagocytic plagues appeared from 3-10 days after infected with AdSU-EGFP.However,when a few cancer cells were infected with AdSU-EGFP and emitted fluorescence after 3 days,the fluorescence emission cells spread within a large area after 7 days.So we can make a conclusion that a novel cancer-selective gene therapeutic oncolytic adenovirus vector system named AdSU,which can selective replicate and express therapeutic genes in cancer cells,was constructed.It is a promising system for targeted cancer gene therapy.